Search bioRxiv⌕ Search

Biology subjects

Milanova, D.

Publications and source records attributed to Milanova, D..

3 recordsLinked to original sources

Inference and validation of causal genetic interactions in aging human fibroblasts

In the past hundred years, the fraction of fatalities due to age-related disease has risen from an envied minority of cases to the leading cause of death and economic morbidity in the developed world. Despite notable advances in understanding aging, its intrinsic complexity has prevented major therapeutic breakthroughs. This complexity extends across all systems and scales in an organism, leaving a "fingerprint of aging" across every aspect of cell and tissue behavior whose interrelationships are difficult to untangle. Compounding this problem, human aging is observed largely through cross-sectional rather than longitudinal data. Whether such data retain sufficient dynamical information to reveal causal interactions is unclear. Here we show that they can. Using convergent cross mapping (CCM), a method for identifying causal interactions in nonlinear dynamical systems, we reconstruct directed genetic interactions from age-ordered, cross-sectional transcriptomic data - recovering dynamics from populations rather than individuals. Applied to dermal fibroblasts from 490 GTEx donors, CCM identifies a genome-scale causal network whose topology, together with age-dependent changes in gene expression, predicts candidate drivers of aging. We tested these predictions experimentally by single-gene overexpression in fibroblasts from 55-year-old donors. Single-cell RNA sequencing confirmed 53.8% of testable CCM-predicted causal interactions, showing that dynamics reconstructed from cross-sectional populations contain experimentally recoverable information about gene-gene interactions. This 53.8% additionally exceeded that produced by multiple comparanda methods and a random null. We then asked whether this information could identify interventions that reverse cellular aging. Independent transcriptomic and high-dimensional morphological assays show that CCM-selected perturbations shift old fibroblasts toward states characteristic of young cells. These two measures of rejuvenation are strongly correlated, and the strongest interventions cause a majority of 55-year-old cells to resemble cells from 25-year-old donors. Thus, causal dynamics can be recovered from cross-sectional population data and used to identify interventions in aging. More generally, the results suggest a way to distinguish genes that change with age from genes that drive those changes, providing experimentally testable targets for altering the aging phenotype.

systems biology↗

Discovery and validation of novel human genomic safe harbor sites for gene and cell therapies

Existing approaches for the integration and expression of genes of interest in a desired human cellular context are marred by the safety concerns related to either the random nature of viral-mediated integration or unpredictable pattern of gene expression in currently employed targeted genomic integration sites. Disadvantages of these methods lead to their limited use in clinical practice, thus encouraging future research in identifying novel human genomic sites that allow for predictable and safe expression of genes of interest. We conducted a bioinformatic search followed by experimental validation of novel genomic sites and identified two that demonstrated stable expression of integrated reporter and therapeutic genes without detrimental changes to cellular transcriptome. The cell-type agnostic criteria used in our bioinformatic search suggest wide-scale applicability of our sites for engineering of a diverse range of tissues for therapeutic as well as enhancement purposes, including modified T-cells for cancer therapy and engineered skin to ameliorate inherited diseases and aging. Additionally, the stable and robust levels of gene expression from identified sites allow for their use in industry-scale biomanufacturing of desired proteins in human cells.

genomics↗

Barcoded oligonucleotides ligated on RNA amplified for multiplex and parallel in-situ analyses

We present Barcoded Oligonucleotides Ligated On RNA Amplified for Multiplexed and parallel In-Situ analysis (BOLORAMIS), a reverse-transcription (RT)-free method for spatially-resolved, targeted, in-situ RNA identification of single or multiple targets. For this proof of concept, we have profiled 154 distinct coding and small non-coding transcripts ranging in sizes 18 nucleotides in length and upwards, from over 200, 000 individual human induced pluripotent stem cells (iPSC) and demonstrated compatibility with multiplexed detection, enabled by fluorescent in-situ sequencing. We use BOLORAMIS data to identify differences in spatial localization and cell-to-cell expression heterogeneity. Our results demonstrate BOLORAMIS to be a generalizable toolset for targeted, in-situ detection of coding and small non-coding RNA for single or multiplexed applications.

cell biology↗